-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Apyx Medical Co. (NASDAQ:APYX) Short Interest Update
Apyx Medical Co. (NASDAQ:APYX) Short Interest Update
Apyx Medical Co. (NASDAQ:APYX – Get Rating) was the recipient of a significant drop in short interest during the month of December. As of December 30th, there was short interest totalling 870,400 shares, a drop of 5.0% from the December 15th total of 916,400 shares. Currently, 2.9% of the company's shares are sold short. Based on an average daily trading volume, of 321,900 shares, the short-interest ratio is presently 2.7 days.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on APYX shares. JMP Securities cut Apyx Medical from an "outperform" rating to a "market perform" rating in a report on Thursday, November 10th. Piper Sandler cut their target price on Apyx Medical to $3.00 in a research note on Wednesday, November 16th. Craig Hallum cut their target price on Apyx Medical to $10.00 in a research note on Wednesday, November 16th. Finally, Lake Street Capital reaffirmed a "buy" rating and set a $5.00 price target on shares of Apyx Medical in a research report on Thursday, December 8th.
Get Apyx Medical alerts:Apyx Medical Trading Up 1.5 %
APYX stock opened at $2.64 on Monday. The business's 50 day simple moving average is $2.06 and its 200 day simple moving average is $4.79. Apyx Medical has a 1-year low of $1.31 and a 1-year high of $12.16. The firm has a market capitalization of $91.34 million, a PE ratio of -4.71 and a beta of 1.20.
Apyx Medical (NASDAQ:APYX – Get Rating) last posted its earnings results on Thursday, November 10th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by ($0.05). The company had revenue of $9.11 million for the quarter, compared to analyst estimates of $12.00 million. Apyx Medical had a negative return on equity of 39.82% and a negative net margin of 39.28%. As a group, sell-side analysts predict that Apyx Medical will post -0.64 EPS for the current fiscal year.Institutional Trading of Apyx Medical
A number of hedge funds have recently modified their holdings of the stock. Taylor Frigon Capital Management LLC lifted its stake in shares of Apyx Medical by 0.6% during the 3rd quarter. Taylor Frigon Capital Management LLC now owns 497,314 shares of the company's stock worth $2,233,000 after buying an additional 3,136 shares during the last quarter. Rhumbline Advisers raised its stake in Apyx Medical by 16.1% in the 1st quarter. Rhumbline Advisers now owns 27,228 shares of the company's stock worth $178,000 after purchasing an additional 3,769 shares in the last quarter. Amalgamated Bank acquired a new stake in Apyx Medical in the 1st quarter worth about $33,000. Goldman Sachs Group Inc. raised its stake in Apyx Medical by 33.5% in the 2nd quarter. Goldman Sachs Group Inc. now owns 22,241 shares of the company's stock worth $130,000 after purchasing an additional 5,580 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. raised its stake in Apyx Medical by 2.1% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 302,606 shares of the company's stock worth $1,976,000 after purchasing an additional 6,150 shares in the last quarter. Institutional investors and hedge funds own 65.55% of the company's stock.
Apyx Medical Company Profile
(Get Rating)
Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME).
Featured Stories
- Get a free copy of the StockNews.com research report on Apyx Medical (APYX)
- Chevron is Likely to Increase its Dividend Before Earnings
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.
阿皮克斯醫療公司(納斯達克代碼:APYX-GET Rating)是空頭股數12月份股價大幅下跌的接收方。截至12月30日,空頭股數共有870,400股,較12月15日的916,400股下降了5.0%。目前,該公司2.9%的股票被賣空。以日均成交量32.19萬股計算,目前短息比為2.7天。
華爾街分析師也加入進來
許多股票分析師已經發布了關於APYX股票的報告。JMP證券在11月10日週四的一份報告中將Apyx Medical的評級從“跑贏大盤”下調至“市場表現”。派珀·桑德勒在11月16日星期三的一份研究報告中將他們對阿皮克斯醫療公司的目標價下調至3.00美元。克雷格·哈勒姆在11月16日星期三的一份研究報告中將其在Apyx Medical的目標價下調至10.00美元。最後,Lake Street Capital在12月8日(星期四)的一份研究報告中重申了買入評級,並為Apyx Medical的股票設定了5.00美元的目標價。
到達阿皮克斯醫療警報:Apyx醫療交易上漲1.5%
APYX股票週一開盤報2.64美元。該業務的50日簡單移動均線切入位為2.06美元,200日簡單移動均線切入位為4.79美元。Apyx Medical的一年低點為1.31美元,一年高位為12.16美元。該公司市值為9134萬美元,本益比為-4.71,貝塔係數為1.20。
阿皮克斯醫療(納斯達克代碼:APYX-GET Rating)最近一次公佈財報是在11月10日星期四。該公司公佈本季度每股收益(EPS)為0.17美元,低於分析師一致預期的0.12美元和0.05美元。該公司本季度營收為911萬美元,而分析師預期為1200萬美元。Apyx Medical的淨資產回報率為負39.82%,淨利潤率為負39.28%。賣方分析師預測,作為一個整體,阿皮克斯醫療公司本財年的每股收益將達到0.64歐元。阿皮克斯醫療的制度性交易
一些對沖基金最近調整了對該股的持有量。Taylor Frigon Capital Management LLC在第三季度增持了Apyx Medical的股份0.6%。Taylor Frigon Capital Management LLC現在持有497,314股該公司股票,價值2,233,000美元,在上個季度又購買了3,136股。Rhumbline Advisers在第一季度將其在Apyx Medical的持股比例提高了16.1%。Rhumbline Advisers在上個季度又購買了3769股,現在擁有27,228股該公司股票,價值17.8萬美元。合併銀行在第一季度收購了Apyx Medical價值約3.3萬美元的新股份。高盛股份有限公司在第二季度增持了33.5%的阿皮克斯醫療股份。高盛股份有限公司在上個季度增持了5,580股後,現在持有22,241股該公司股票,價值130,000美元。最後,雷蒙德·詹姆斯金融服務顧問公司(Raymond James Financial Services Advisors Inc.)在第一季度將其在Apyx Medical的持股比例提高了2.1%。雷蒙德·詹姆斯金融服務顧問公司(Raymond James Financial Services Advisors Inc.)現在持有302,606股該公司股票,價值1,976,000美元,此前該公司在上個季度又購買了6,150股。機構投資者和對沖基金持有該公司65.55%的股票。
Apyx醫療公司簡介
(獲取評級)
阿皮克斯醫療公司是一家以能源為基礎的醫療技術公司。該公司致力於開發、製造和營銷一系列電外科產品和技術,以及用於世界各地醫生、手術中心和醫院辦公室的相關醫療產品。它通過以下部門運營:先進能源和原始設備製造(OME)。
專題報道
- 免費獲取StockNews.com關於Apyx Medical(APYX)的研究報告
- 雪佛龍可能在盈利前增加派息
- 市場回顧周-1/16-1/20
- Old Dominion是否表明Trucking正在踩剎車?
- 諾德斯特龍對零售業降價的擔憂
- 埃克森美孚股票:在Buy Point附近
接受《阿皮克斯醫學日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Apyx Medical和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧